Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Medication Switching for Plateau Breakthrough The first clinical option is a dose increase
At a San Diego conference last year, I presented data from 403 bariatric patients showing that while outcomes were similar across income levels after a year, patients from the lowest socioeconomic areas showed significantly lower weight loss and follow-up rates after three years
Live Younger Improving your VO2max by 12% is like turning your body clock back 10 years
ABSTRACT KEY FIGURE Highlights INTRODUCTION DISCOVERY OF GLP-1 AND DEVELOPMENT OF INCRETIN-BASED DRUGS GLP-1 AND IMPLICATIONS IN COGNITIVE SATIATION: HUMAN STUDIES HYPOTHALAMIC FUNCTIONS IN COGNITIVE FEED-FORWARD REGULATION HYPOTHALAMIC CONTROL OF GLP-1 ACTIONS ON SATIATION AND SATIETY: ANIMAL STUDIES ONGOING FUTURE STUDIES OF GLP-1R AGONISTS NOTES REFERENCES About this article ABSTRACT Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as blockbuster drugs for treating metabolic diseases
Endocrinol Diabetes Nutr 64:182184
US$ 20.78
US$ 25.66
US$ 27.92
